Skip to main content
Top
Published in: AIDS Research and Therapy 1/2011

Open Access 01-12-2011 | Research

Multiple shRNA combinations for near-complete coverage of all HIV-1 strains

Authors: Glen J Mcintyre, Jennifer L Groneman, Yi-Hsin Yu, Anna Tran, Tanya L Applegate

Published in: AIDS Research and Therapy | Issue 1/2011

Login to get access

Abstract

Background

Combinatorial RNA interference (co-RNAi) approaches are needed to account for viral variability in treating HIV-1 with RNAi, as single short hairpin RNAs (shRNA) are rapidly rendered ineffective by resistant strains. Current work suggests that 4 simultaneously expressed shRNAs may prevent the emergence of resistant strains.

Results

In this study we assembled combinations of highly-conserved shRNAs to target as many HIV-1 strains as possible. We analyzed intersecting conservations of 10 shRNAs to find combinations with 4+ matching the maximum number of strains using 1220+ HIV-1 sequences from the Los Alamos National Laboratory (LANL). We built 26 combinations of 2 to 7 shRNAs with up to 87% coverage for all known strains and 100% coverage of clade B subtypes, and characterized their intrinsic suppressive activities in transient expression assays. We found that all combinations had high combined suppressive activities, though there were also large changes in the individual activities of the component shRNAs in our multiple expression cassette configurations.

Conclusion

By considering the intersecting conservations of shRNA combinations we have shown that it is possible to assemble combinations of 6 and 7 highly active, highly conserved shRNAs such that there is always at least 4 shRNAs within each combination covering all currently known variants of entire HIV-1 subtypes. By extension, it may be possible to combine several combinations for complete global coverage of HIV-1 variants.
Appendix
Available only for authorised users
Literature
2.
go back to reference LANL: Los Alamos National Laboratory HIV sequence database. 2006 LANL: Los Alamos National Laboratory HIV sequence database. 2006
3.
go back to reference Yeni P: Update on HAART in HIV. J Hepatol. 2006, 44 (Suppl 1:): S100-103. 10.1016/j.jhep.2005.11.021CrossRefPubMed Yeni P: Update on HAART in HIV. J Hepatol. 2006, 44 (Suppl 1:): S100-103. 10.1016/j.jhep.2005.11.021CrossRefPubMed
4.
go back to reference Zamore PD, Haley B: Ribo-gnome: the big world of small RNAs. Science. 2005, 309: 1519-1524. 10.1126/science.1111444CrossRefPubMed Zamore PD, Haley B: Ribo-gnome: the big world of small RNAs. Science. 2005, 309: 1519-1524. 10.1126/science.1111444CrossRefPubMed
5.
go back to reference Hannon GJ, Rossi JJ: Unlocking the potential of the human genome with RNA interference. Nature. 2004, 431: 371-378. 10.1038/nature02870CrossRefPubMed Hannon GJ, Rossi JJ: Unlocking the potential of the human genome with RNA interference. Nature. 2004, 431: 371-378. 10.1038/nature02870CrossRefPubMed
6.
go back to reference Stevenson M: Therapeutic potential of RNA interference. N Engl J Med. 2004, 351: 1772-1777. 10.1056/NEJMra045004CrossRefPubMed Stevenson M: Therapeutic potential of RNA interference. N Engl J Med. 2004, 351: 1772-1777. 10.1056/NEJMra045004CrossRefPubMed
7.
go back to reference Dickins RA, Hemann MT, Zilfou JT, Simpson DR, Ibarra I, Hannon GJ, Lowe SW: Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet. 2005, 37: 1163-1165. 10.1038/ng1105-1163CrossRef Dickins RA, Hemann MT, Zilfou JT, Simpson DR, Ibarra I, Hannon GJ, Lowe SW: Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet. 2005, 37: 1163-1165. 10.1038/ng1105-1163CrossRef
8.
go back to reference Rubinson D, Dillon C, Kwiatkowski A, Sievers C, Yang L, Kopinja J, Rooney D, Ihrig M, McManus M, Gertler F: A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet. 2003, 33: 401-406. 10.1038/ng1117CrossRefPubMed Rubinson D, Dillon C, Kwiatkowski A, Sievers C, Yang L, Kopinja J, Rooney D, Ihrig M, McManus M, Gertler F: A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet. 2003, 33: 401-406. 10.1038/ng1117CrossRefPubMed
9.
go back to reference Lee M, Coburn G, McClure M, Cullen B: Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol. 2003, 77: 11964-11972. 10.1128/JVI.77.22.11964-11972.2003PubMedCentralCrossRefPubMed Lee M, Coburn G, McClure M, Cullen B: Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol. 2003, 77: 11964-11972. 10.1128/JVI.77.22.11964-11972.2003PubMedCentralCrossRefPubMed
10.
go back to reference Naito , Nohtomi , Onogi , Uenishi , Ui-Tei , Saigo , Takebe : Optimal design and validation of antiviral siRNA for targeting HIV-1. Retrovirology. 2007, 4: 80- 10.1186/1742-4690-4-80PubMedCentralCrossRefPubMed Naito , Nohtomi , Onogi , Uenishi , Ui-Tei , Saigo , Takebe : Optimal design and validation of antiviral siRNA for targeting HIV-1. Retrovirology. 2007, 4: 80- 10.1186/1742-4690-4-80PubMedCentralCrossRefPubMed
11.
go back to reference ter Brake O, Konstantinova P, Ceylan M, Berkhout B: Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther. 2006, 14: 883-892. 10.1016/j.ymthe.2006.07.007CrossRefPubMed ter Brake O, Konstantinova P, Ceylan M, Berkhout B: Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther. 2006, 14: 883-892. 10.1016/j.ymthe.2006.07.007CrossRefPubMed
12.
go back to reference Mcintyre G, Groneman J, Yu Y, Jaramillo A, Shen S, Applegate T: 96 shRNAs designed for maximal coverage of HIV-1 variants. Retrovirology. 2009, 6: 55- 10.1186/1742-4690-6-55PubMedCentralCrossRefPubMed Mcintyre G, Groneman J, Yu Y, Jaramillo A, Shen S, Applegate T: 96 shRNAs designed for maximal coverage of HIV-1 variants. Retrovirology. 2009, 6: 55- 10.1186/1742-4690-6-55PubMedCentralCrossRefPubMed
13.
go back to reference Das AT, Brummelkamp TR, Westerhout , Vink M, Madiredjo M, Bernards R, Berkhout B: Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. Journal of Virology. 2004, 78: 2601-2605. 10.1128/JVI.78.5.2601-2605.2004PubMedCentralCrossRefPubMed Das AT, Brummelkamp TR, Westerhout , Vink M, Madiredjo M, Bernards R, Berkhout B: Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. Journal of Virology. 2004, 78: 2601-2605. 10.1128/JVI.78.5.2601-2605.2004PubMedCentralCrossRefPubMed
14.
go back to reference Boden , Pusch , Lee , Tucker , Ramratnam : Human immunodeficiency virus type 1 escape from RNA interference. Journal of Virology. 2003, 77: 11531-11535. 10.1128/JVI.77.21.11531-11535.2003PubMedCentralCrossRefPubMed Boden , Pusch , Lee , Tucker , Ramratnam : Human immunodeficiency virus type 1 escape from RNA interference. Journal of Virology. 2003, 77: 11531-11535. 10.1128/JVI.77.21.11531-11535.2003PubMedCentralCrossRefPubMed
15.
go back to reference Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B: HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 2005, 33: 796-804. 10.1093/nar/gki220PubMedCentralCrossRefPubMed Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B: HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 2005, 33: 796-804. 10.1093/nar/gki220PubMedCentralCrossRefPubMed
16.
go back to reference Nishitsuji : Effective Suppression of Human Immunodeficiency Virus Type 1 through a Combination of Short- or Long-Hairpin RNAs Targeting Essential Sequences for Retroviral Integration. Journal of Virology. 2006, 80: 7658-7666. 10.1128/JVI.00078-06PubMedCentralCrossRefPubMed Nishitsuji : Effective Suppression of Human Immunodeficiency Virus Type 1 through a Combination of Short- or Long-Hairpin RNAs Targeting Essential Sequences for Retroviral Integration. Journal of Virology. 2006, 80: 7658-7666. 10.1128/JVI.00078-06PubMedCentralCrossRefPubMed
17.
go back to reference Ter brake O, Berkhout B: A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs. Journal of RNAi and Gene Silencing. 2005, 1: 56-65.PubMedCentralPubMed Ter brake O, Berkhout B: A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs. Journal of RNAi and Gene Silencing. 2005, 1: 56-65.PubMedCentralPubMed
18.
go back to reference Wilson J, Richardson C: Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. J Virol. 2005, 79: 7050-7058. 10.1128/JVI.79.11.7050-7058.2005PubMedCentralCrossRefPubMed Wilson J, Richardson C: Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. J Virol. 2005, 79: 7050-7058. 10.1128/JVI.79.11.7050-7058.2005PubMedCentralCrossRefPubMed
19.
go back to reference Leonard JN, Schaffer DV: Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. Journal of Virology. 2005, 79: 1645-1654. 10.1128/JVI.79.3.1645-1654.2005PubMedCentralCrossRefPubMed Leonard JN, Schaffer DV: Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. Journal of Virology. 2005, 79: 1645-1654. 10.1128/JVI.79.3.1645-1654.2005PubMedCentralCrossRefPubMed
20.
go back to reference Applegate TL, Birkett DJ, McIntyre GJ, Jaramillo AB, Symonds G, Murray JM: In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy. Retrovirology. 2010, 7: 83- 10.1186/1742-4690-7-83PubMedCentralCrossRefPubMed Applegate TL, Birkett DJ, McIntyre GJ, Jaramillo AB, Symonds G, Murray JM: In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy. Retrovirology. 2010, 7: 83- 10.1186/1742-4690-7-83PubMedCentralCrossRefPubMed
21.
go back to reference Liu , Haasnoot , Berkhout : Design of extended short hairpin RNAs for HIV-1 inhibition. Nucleic Acids Research. 2007, 35: 5683-5693. 10.1093/nar/gkm596PubMedCentralCrossRefPubMed Liu , Haasnoot , Berkhout : Design of extended short hairpin RNAs for HIV-1 inhibition. Nucleic Acids Research. 2007, 35: 5683-5693. 10.1093/nar/gkm596PubMedCentralCrossRefPubMed
22.
go back to reference Liu , Haasnoot , Brake T, Berkhout , Konstantinova : Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Research. 2008, 36: 2811-2824. 10.1093/nar/gkn109PubMedCentralCrossRefPubMed Liu , Haasnoot , Brake T, Berkhout , Konstantinova : Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Research. 2008, 36: 2811-2824. 10.1093/nar/gkn109PubMedCentralCrossRefPubMed
23.
go back to reference Brake O, Hooft K, Liu Y, Centlivre M, Jasmijn von Eije K, Berkhout B: Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition. Mol Ther. 2008, 16: 557-564. 10.1038/sj.mt.6300382CrossRefPubMed Brake O, Hooft K, Liu Y, Centlivre M, Jasmijn von Eije K, Berkhout B: Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition. Mol Ther. 2008, 16: 557-564. 10.1038/sj.mt.6300382CrossRefPubMed
24.
go back to reference Yu JY, Taylor J, DeRuiter SL, Vojtek AB, Turner DL: Simultaneous inhibition of GSK3alpha and GSK3beta using hairpin siRNA expression vectors. Mol Ther. 2003, 7: 228-236. 10.1016/S1525-0016(02)00037-0CrossRefPubMed Yu JY, Taylor J, DeRuiter SL, Vojtek AB, Turner DL: Simultaneous inhibition of GSK3alpha and GSK3beta using hairpin siRNA expression vectors. Mol Ther. 2003, 7: 228-236. 10.1016/S1525-0016(02)00037-0CrossRefPubMed
25.
go back to reference Schuck S, Manninen A, Honsho M, Fullekrug J, Simons K: Generation of single and double knockdowns in polarized epithelial cells by retrovirus-mediated RNA interference. Proc Natl Acad Sci USA. 2004, 101: 4912-4917. 10.1073/pnas.0401285101PubMedCentralCrossRefPubMed Schuck S, Manninen A, Honsho M, Fullekrug J, Simons K: Generation of single and double knockdowns in polarized epithelial cells by retrovirus-mediated RNA interference. Proc Natl Acad Sci USA. 2004, 101: 4912-4917. 10.1073/pnas.0401285101PubMedCentralCrossRefPubMed
26.
go back to reference Anderson J, Akkina R: HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. AIDS Res Ther. 2005, 2: 1- 10.1186/1742-6405-2-1PubMedCentralCrossRefPubMed Anderson J, Akkina R: HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. AIDS Res Ther. 2005, 2: 1- 10.1186/1742-6405-2-1PubMedCentralCrossRefPubMed
27.
go back to reference Gonzalez S, Castanotto D, Li H, Olivares S, Jensen MC, Forman SJ, Rossi JJ, Cooper LJ: Amplification of RNAi--targeting HLA mRNAs. Mol Ther. 2005, 11: 811-818. 10.1016/j.ymthe.2004.12.023CrossRefPubMed Gonzalez S, Castanotto D, Li H, Olivares S, Jensen MC, Forman SJ, Rossi JJ, Cooper LJ: Amplification of RNAi--targeting HLA mRNAs. Mol Ther. 2005, 11: 811-818. 10.1016/j.ymthe.2004.12.023CrossRefPubMed
28.
go back to reference Saayman , Barichievy , Capovilla , Morris , Arbuthnot , Weinberg , Bowyer : The Efficacy of Generating Three Independent Anti-HIV-1 siRNAs from a Single U6 RNA Pol III-Expressed Long Hairpin RNA. PLoS ONE. 2008, 3: e2602- 10.1371/journal.pone.0002602PubMedCentralCrossRefPubMed Saayman , Barichievy , Capovilla , Morris , Arbuthnot , Weinberg , Bowyer : The Efficacy of Generating Three Independent Anti-HIV-1 siRNAs from a Single U6 RNA Pol III-Expressed Long Hairpin RNA. PLoS ONE. 2008, 3: e2602- 10.1371/journal.pone.0002602PubMedCentralCrossRefPubMed
29.
go back to reference Sano , Li , Nakanishi , Rossi : Expression of Long Anti-HIV-1 Hairpin RNAs for the Generation of Multiple siRNAs: Advantages and Limitations. Mol Ther. 2008, 16: 170-177. 10.1038/sj.mt.6300298CrossRefPubMed Sano , Li , Nakanishi , Rossi : Expression of Long Anti-HIV-1 Hairpin RNAs for the Generation of Multiple siRNAs: Advantages and Limitations. Mol Ther. 2008, 16: 170-177. 10.1038/sj.mt.6300298CrossRefPubMed
30.
go back to reference Zhu X, Santat LA, Chang MS, Liu J, Zavzavadjian JR, Wall EA, Kivork C, Simon MI, Fraser ID: A versatile approach to multiple gene RNA interference using microRNA-based short hairpin RNAs. BMC Mol Biol. 2007, 8: 98- 10.1186/1471-2199-8-98PubMedCentralCrossRefPubMed Zhu X, Santat LA, Chang MS, Liu J, Zavzavadjian JR, Wall EA, Kivork C, Simon MI, Fraser ID: A versatile approach to multiple gene RNA interference using microRNA-based short hairpin RNAs. BMC Mol Biol. 2007, 8: 98- 10.1186/1471-2199-8-98PubMedCentralCrossRefPubMed
31.
go back to reference Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004, 116: 281-297. 10.1016/S0092-8674(04)00045-5CrossRefPubMed Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004, 116: 281-297. 10.1016/S0092-8674(04)00045-5CrossRefPubMed
32.
go back to reference Kim V: MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005, 6: 376-385. 10.1038/nrm1644CrossRefPubMed Kim V: MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005, 6: 376-385. 10.1038/nrm1644CrossRefPubMed
33.
go back to reference Mcintyre GJ: Antiviral shRNA for HIV-1. Ph.D. 2006, The University of New South Wales (UNSW), The School of Biotechnology and Biomolecular Sciences (BABS); Mcintyre GJ: Antiviral shRNA for HIV-1. Ph.D. 2006, The University of New South Wales (UNSW), The School of Biotechnology and Biomolecular Sciences (BABS);
34.
go back to reference Liu YP, Eije KJv, Schopman NC, Westerink J-T, Brake Ot, Haasnoot J, Berkhout B: Combinatorial RNAi Against HIV-1 Using Extended Short Hairpin RNAs. Molecular Therapy. 2010, 17: 1712-1723. 10.1038/mt.2009.176.CrossRef Liu YP, Eije KJv, Schopman NC, Westerink J-T, Brake Ot, Haasnoot J, Berkhout B: Combinatorial RNAi Against HIV-1 Using Extended Short Hairpin RNAs. Molecular Therapy. 2010, 17: 1712-1723. 10.1038/mt.2009.176.CrossRef
35.
go back to reference Gou , Weng , Wang , Wang , Zhang , Gao , Chen , Wang , Liu : A novel approach for the construction of multiple shRNA expression vectors. J Gene Med. 2007, 9: 751-763. 10.1002/jgm.1080CrossRefPubMed Gou , Weng , Wang , Wang , Zhang , Gao , Chen , Wang , Liu : A novel approach for the construction of multiple shRNA expression vectors. J Gene Med. 2007, 9: 751-763. 10.1002/jgm.1080CrossRefPubMed
36.
go back to reference Henry , Vanderwegen , Metselaar , Tilanus , Scholte , Vanderlaan : Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Mol Ther. 2006, 14: 485-493. 10.1016/j.ymthe.2006.04.012CrossRefPubMed Henry , Vanderwegen , Metselaar , Tilanus , Scholte , Vanderlaan : Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Mol Ther. 2006, 14: 485-493. 10.1016/j.ymthe.2006.04.012CrossRefPubMed
37.
go back to reference Naito Y, Nohtomi K, Onogi T, Uenishi R, Ui-Tei K, Saigo K, Takebe Y: Optimal design and validation of antiviral siRNA for targeting HIV-1. Retrovirology. 2007, 4: 80- 10.1186/1742-4690-4-80PubMedCentralCrossRefPubMed Naito Y, Nohtomi K, Onogi T, Uenishi R, Ui-Tei K, Saigo K, Takebe Y: Optimal design and validation of antiviral siRNA for targeting HIV-1. Retrovirology. 2007, 4: 80- 10.1186/1742-4690-4-80PubMedCentralCrossRefPubMed
38.
go back to reference Mcintyre G, Groneman J, Tran A, Applegate T: An Infinitely Expandable Cloning Strategy plus Repeat-Proof PCR for Working with Multiple shRNA. PLoS ONE. 2008, 3: e3827- 10.1371/journal.pone.0003827PubMedCentralCrossRefPubMed Mcintyre G, Groneman J, Tran A, Applegate T: An Infinitely Expandable Cloning Strategy plus Repeat-Proof PCR for Working with Multiple shRNA. PLoS ONE. 2008, 3: e3827- 10.1371/journal.pone.0003827PubMedCentralCrossRefPubMed
39.
go back to reference Coburn G, Cullen B: Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol. 2002, 76: 9225-9231. 10.1128/JVI.76.18.9225-9231.2002PubMedCentralCrossRefPubMed Coburn G, Cullen B: Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol. 2002, 76: 9225-9231. 10.1128/JVI.76.18.9225-9231.2002PubMedCentralCrossRefPubMed
40.
go back to reference Jacque J, Triques K, Stevenson M: Modulation of HIV-1 replication by RNA interference. Nature. 2002, 418: 435-438. 10.1038/nature00896CrossRefPubMed Jacque J, Triques K, Stevenson M: Modulation of HIV-1 replication by RNA interference. Nature. 2002, 418: 435-438. 10.1038/nature00896CrossRefPubMed
41.
go back to reference Hu W, Myers C, Kilzer J, Pfaff S, Bushman F: Inhibition of retroviral pathogenesis by RNA interference. Curr Biol. 2002, 12: 1301-1311. 10.1016/S0960-9822(02)00975-2CrossRefPubMed Hu W, Myers C, Kilzer J, Pfaff S, Bushman F: Inhibition of retroviral pathogenesis by RNA interference. Curr Biol. 2002, 12: 1301-1311. 10.1016/S0960-9822(02)00975-2CrossRefPubMed
42.
go back to reference Cullen B: Induction of stable RNA interference in mammalian cells. Gene Ther. 2005, 13: 503-508. 10.1038/sj.gt.3302656.CrossRef Cullen B: Induction of stable RNA interference in mammalian cells. Gene Ther. 2005, 13: 503-508. 10.1038/sj.gt.3302656.CrossRef
43.
go back to reference Giering JC, Grimm D, Storm TA, Kay MA: Expression of shRNA From a Tissue-specific pol II Promoter Is an Effective and Safe RNAi Therapeutic. Mol Ther. 2008, 16: 1630-1636. 10.1038/mt.2008.144CrossRefPubMed Giering JC, Grimm D, Storm TA, Kay MA: Expression of shRNA From a Tissue-specific pol II Promoter Is an Effective and Safe RNAi Therapeutic. Mol Ther. 2008, 16: 1630-1636. 10.1038/mt.2008.144CrossRefPubMed
44.
go back to reference Liu YP, Haasnoot J, Ter Brake O, Berkhout B, Konstantinova P: Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Research. 2008, 36: 2811-2824. 10.1093/nar/gkn109PubMedCentralCrossRefPubMed Liu YP, Haasnoot J, Ter Brake O, Berkhout B, Konstantinova P: Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Research. 2008, 36: 2811-2824. 10.1093/nar/gkn109PubMedCentralCrossRefPubMed
45.
go back to reference McIntyre G, Yu Y, Tran A, Jaramillo A, Arndt A, Millington M, Boyd M, Elliott F, Shen S, Murray J, Applegate T: Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success. Virol J. 2009, 6: 184- 10.1186/1743-422X-6-184PubMedCentralCrossRefPubMed McIntyre G, Yu Y, Tran A, Jaramillo A, Arndt A, Millington M, Boyd M, Elliott F, Shen S, Murray J, Applegate T: Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success. Virol J. 2009, 6: 184- 10.1186/1743-422X-6-184PubMedCentralCrossRefPubMed
46.
go back to reference Berkhout B: RNA interference as an antiviral approach: targeting HIV-1. Curr Opin Mol Ther. 2004, 6: 141-145.PubMed Berkhout B: RNA interference as an antiviral approach: targeting HIV-1. Curr Opin Mol Ther. 2004, 6: 141-145.PubMed
47.
go back to reference Lee NS, Rossi JJ: Control of HIV-1 replication by RNA interference. Virus Res. 2004, 102: 53-58. 10.1016/j.virusres.2004.01.015CrossRefPubMed Lee NS, Rossi JJ: Control of HIV-1 replication by RNA interference. Virus Res. 2004, 102: 53-58. 10.1016/j.virusres.2004.01.015CrossRefPubMed
48.
go back to reference Haasnoot , Westerhout , Berkhout : RNA interference against viruses: strike and counterstrike. Nat Biotechnol. 2007, 25: 1435-1443. 10.1038/nbt1369CrossRefPubMed Haasnoot , Westerhout , Berkhout : RNA interference against viruses: strike and counterstrike. Nat Biotechnol. 2007, 25: 1435-1443. 10.1038/nbt1369CrossRefPubMed
49.
go back to reference Leonard JN, Schaffer DV: Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. J Virol. 2005, 79: 1645-1654. 10.1128/JVI.79.3.1645-1654.2005PubMedCentralCrossRefPubMed Leonard JN, Schaffer DV: Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. J Virol. 2005, 79: 1645-1654. 10.1128/JVI.79.3.1645-1654.2005PubMedCentralCrossRefPubMed
50.
Metadata
Title
Multiple shRNA combinations for near-complete coverage of all HIV-1 strains
Authors
Glen J Mcintyre
Jennifer L Groneman
Yi-Hsin Yu
Anna Tran
Tanya L Applegate
Publication date
01-12-2011
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2011
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/1742-6405-8-1

Other articles of this Issue 1/2011

AIDS Research and Therapy 1/2011 Go to the issue